Tag: licensing
-
Crispr Heart Therapy Demonstrated in Monkeys
An experimental therapy using a precise gene editing technique is shown in lab monkeys to reverse the cause of a chronic form of heart disease.
-
Virtual Drug Discovery Incubator Launched for Univ. Labs
Life science investors and a drug discovery company started a remote business incubator service to discover and develop early therapy candidates from academic research.
-
Non-Invasive Fetal Oxygen Monitor Designed
A university engineering lab created a device that safely monitors a fetus’s blood oxygen levels from outside the mother’s abdomen, which could reduce the rate of cesarean sections.
-
Crispr Heart Disease Start-Up Raises New $63M
A one year-old company developing a one-time gene-editing treatment for coronary artery disease is adding $63 million to its first venture funding round.
-
Cancer Drug Technology Licensed for Covid-19
A biotechnology company is licensing medical research discoveries from university labs first designed for treating cancer as a potential Covid-19 therapy.
-
Industry, Univ. Labs Partner on Covid-19 Therapy
Researchers from industry and academic labs are developing a synthetic antibody that in lab tests shows promise as both a Covid-19 therapy and vaccine.
-
Start-Up Creating a Simpler, Stable Liquid Biopsy
A new company spun off from University of Oxford is developing a stable and sensitive blood test to detect multiple types of cancer in their early stages.
-
Biotechs Apply Crispr Gene-Editing for Hemophilia
A treatment for the blood disease hemophilia and other inherited disorders are being developed with the gene-editing technology Crispr in a biotechnology deal.
-
Drug Maker Licenses Low-Dose Vaccine Patch
The pharmaceutical company Merck is licensing a microneedle patch device that delivers vaccines with a small fraction of the dose normally needed by syringes.
-
Health Research Commercialization Company Launched
University of Michigan and health care investor Deerfield Management are creating a new enterprise to bring promising academic life science research to market.